GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cyxone AB (FRA:4CX) » Definitions » Margin of Safety % (DCF FCF Based)

Cyxone AB (FRA:4CX) Margin of Safety % (DCF FCF Based) : N/A (As of Mar. 31, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Cyxone AB Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Cyxone AB's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

Competitive Comparison of Cyxone AB's Margin of Safety % (DCF FCF Based)

For the Biotechnology subindustry, Cyxone AB's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cyxone AB's Margin of Safety % (DCF FCF Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cyxone AB's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Cyxone AB's Margin of Safety % (DCF FCF Based) falls into.


;
;

Cyxone AB Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of Cyxone AB's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyxone AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cyxone AB (FRA:4CX) » Definitions » Margin of Safety % (DCF FCF Based)
Comparable Companies
OSTO:2CUREX XSAT:WNT OSTO:DIABIO OSTO:LIDDS OSTO:ZICC XSAT:ALTE OSTO:FLUI OSTO:LPGO OSTO:QUIA XSAT:APTA VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
Hyllie Boulevard 34, Malmo, SWE, 215 32
Website
https://www.cyxone.com
Cyxone AB is a clinical biotech company with a portfolio of immunomodulating drugs for the treatment of autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA). The product candidates of the company include T20K and Rabeximod.

Cyxone AB Headlines

No Headlines